Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
    about 20 hours ago
  • New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
    about 20 hours ago
  • I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
    about 2 days ago
  • Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
    about 3 days ago
  • A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
    about 3 days ago

Please share Science & Enterprise

Trial Underway Testing Insulin Capsules

Capsules

Researchers began screening participants for a clinical trial assessing insulin formulated as capsules for people with type 2 diabetes. . . . → Read More: Trial Underway Testing Insulin Capsules

Nanoscale Particles Deliver Crispr Cancer Treatments

Crispr-Cas9 illustration

Researchers in Israel developed techniques to deliver gene editing therapies with lipid nanoscale particles that in lab mice killed cancer cells and increased survival. . . . → Read More: Nanoscale Particles Deliver Crispr Cancer Treatments

Precision Drug Trial Shows Solid Tumor Shrinkage

Cancer on clipboard

Partial results from a clinical trial show a drug to stop specific cancer-causing proteins shrinks advanced tumors in some patients across several tumor types. . . . → Read More: Precision Drug Trial Shows Solid Tumor Shrinkage

Wearable Device Shown to Relieve Migraine Pain

Brain activity graphic

Evidence collected from electronic neuro-stimulation devices shows for most people the wearable systems relieve migraine pain without other drugs. . . . → Read More: Wearable Device Shown to Relieve Migraine Pain

Start-Up to Engineer T-Cells for Autoimmune Diseases

Human T-cell

GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases. . . . → Read More: Start-Up to Engineer T-Cells for Autoimmune Diseases

Ultrasound Boosts Cancer Gene Therapy

Cancer magnified

Ultrasound waves are shown in tests with lab mice to increase the uptake of a gene therapy that invokes the immune system in treating solid tumor cancers. . . . → Read More: Ultrasound Boosts Cancer Gene Therapy

Contact Lens Material Reduces Color Blindness

Red-blue-green eye

An engineered ultra-thin material designed for contact lenses is shown in lab tests to help correct for a common form of color blindness. . . . → Read More: Contact Lens Material Reduces Color Blindness

Ingested X-Ray Capsule Shown Safe, Feasible

C-Scan capsule

Results from a small-scale clinical trial show an ingested capsule to diagnose potential colon tumors is safe and feasible for most patients. . . . → Read More: Ingested X-Ray Capsule Shown Safe, Feasible

First Therapies Selected for Multi-Drug ALS Trial

Brain cell networks

A clinical trial is getting underway to test five treatment candidates for amyotrophic lateral sclerosis, or ALS, beginning with the first three therapies. . . . → Read More: First Therapies Selected for Multi-Drug ALS Trial

Stanford, Berkeley, MIT Top Undergrad Start-Up Ranking

Shop open sign

Stanford University, University of California in Berkeley, and Massachusetts Institute of Technology lead the undergraduate programs producing founders of start-up companies in 2019. . . . → Read More: Stanford, Berkeley, MIT Top Undergrad Start-Up Ranking